Reporte zur Charge EN06205

Symptomtext

Next monthly menstrual cycle was extremely heavy with clots and has continued since that second vaccine So, March 2021 to this date the cycle have been horrible.; This is a spontaneous report from a contactable other healthcare professional. A 46-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN06205) via an unspecified route of administration in the arm left on 05Mar2021 at 16:00 (at the age of 46-year-old) and the patient also received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8732) via an unspecified route of administration in the arm left on an unknown date in 2021, as a single dose for COVID-19 immunisation. Medical history included kidney transplant. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medication included immunosuppressants (MANUFACTURER UNKNOWN), from an unknown date for kidney transplant and unknown if ongoing. On an unknown date in Mar2021, the patient experienced next monthly menstrual cycle was extremely heavy with clots and had continued since that second vaccine So, March 2021 to this date the cycle had been horrible. On an unknown date, the patient underwent SARS CoV-2 test (blood test) and the result was unknown. On an unknown date, the patient underwent antibody test and the result was no/undetectable antibodies. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had been tested for COVID-19. The clinical outcome of the event, menstrual cycle was extremely heavy with clots and had continued since that second vaccine was unknown at the time of the report.